Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner.
about
Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucansInduction of keratinocyte growth factor 1 Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.Subgingival Plaque in Periodontal Health Antagonizes at Toll-Like Receptor 4 and Inhibits E-Selectin Expression on Endothelial Cells.Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expressionSynergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparationsLipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteriaInsertional inactivation of pac and rmlB genes reduces the release of tumor necrosis factor alpha, interleukin-6, and interleukin-8 induced by Streptococcus mutans in monocytic, dental pulp, and periodontal ligament cellsAugmentation of Actinobacillus actinomycetemcomitans invasion of human oral epithelial cells and up-regulation of interleukin-8 production by saliva CD14.
P2860
Q34007926-4F42631F-ED48-4099-BBCB-62468AF4D65EQ34258269-BE3F7863-DD67-44B1-AE3B-AF83C8E8301EQ34487226-1E6BBB6A-9A79-4832-B342-38FFA09AE6C7Q36411004-BCB5568D-B0FA-474E-94D6-D9000F2D61DAQ38313244-A1D117C2-A274-4F25-80CD-4D49E3F226C6Q39519164-E2685386-EDC3-4C38-9F7A-5328EE5DB835Q39653924-0D7A2E11-1434-4936-9904-D6DB1998D90AQ39654596-C704D293-A7F2-465C-9CC5-1FC437447E11Q39863826-47E550F8-34BC-4B8C-AFCB-1A82927ADE1FQ39913163-56974FB1-12CA-4D6A-97B7-990DF5B8A3BE
P2860
Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@en
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@nl
type
label
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@en
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@nl
prefLabel
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@en
Lipoteichoic acid acts as an a ...... es in a CD14-dependent manner.
@nl
P2093
P2860
P1476
Lipoteichoic acid acts as an a ...... tes in a CD14-dependent manner
@en
P2093
P2860
P304
P407
P577
1999-04-01T00:00:00Z